Newsfeed Should PARP Inhibitors Have Tumor-Agnostic Approval Status? author Let's Win! Pancreatic Cancer 27 August, 2019 Listen to Maurie Markman, MD discuss PARP inhibitors. Watch here. . . Related Stories Newsfeed VIDEO: Niraparib-Ipilimumab Maintenance Prevents Advanced Pancreatic Cancer ProgressionLet's Win! Pancreatic Cancer Newsfeed VIDEO: Chemotherapy Retains Some Activity After Pancreatic Cancer Progression on RucaparibLet's Win! Pancreatic Cancer Newsfeed Smoking and Pancreatic Cancer: Smoking Patterns, Tobacco Type, and Dose-Response RelationshipLet's Win! Pancreatic Cancer